Source: ERJ Open Res, 4 (2) 00060-2017; 10.1183/23120541.00060-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Mikhail P. Kostinov, Alexander P. Cherdantsev, Nelli K. Akhmatova, Daria A. Praulova, Aristitsa M. Kostinova, Elina A. Akhmatova, Evgeniia O. Demina. Immunogenicity and safety of subunit influenza vaccines in pregnant women. ERJ Open Res, 4 (2) 00060-2017; 10.1183/23120541.00060-2017

Member's Comments

No comment yet.

Related content which might interest you: Immunogenicity and safety of a novel recombinant pandemic influenza vaccine containing a polysaccharide adjuvant Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Safety and immunogenicity of a dose-sparing, trivalent inactivated seasonal influenza vaccine containing an advax adjuvant – a phase 1/2 randomised controlled trial Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Immunological and clinical efficacy of flu vaccination in toddlers Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009 A randomized, open-label, parallel design study to compare the immunogenicity of simultaneous administration versus sequential administration of quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in the elderly Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD Source: Virtual Congress 2021 – Pneumonia Year: 2021 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 The relation of people to vaccination against an influenza virus Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Searching for a pandemic influenza vaccine Source: International Congress 2014 – Virulent topics in respiratory infections Year: 2014 Pneumococcal and influenza vaccination Source: Eur Respir Monogr 2014; 63: 266-284 Year: 2014 Antibody response to influenza vaccine in patients with sarcoidosis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 A randomised controlled trial comparing the immunogenicity, safety and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a needless injector device versus a traditional pre-filled syringe and needle Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 673s Year: 2005 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Influenza and pneumococcal vaccination Source: International Congress 2017 – State of the art session: "Respiratory infections" Year: 2017 Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010 Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010